Ebb Therapeutics

company

About

Ebb Therapeutics develops regional cerebral thermal therapy (RCTT) device for use in insomnia and sleep disorders.

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$38M
Industries
Genetics,Health Care,Life Science,Medical,Medical Device,Therapeutics
Founded date
Jan 1, 2008
Number Of Employee
11 - 50
Operating Status
Active

Ebb Therapeutics develops regional cerebral thermal therapy (RCTT) device for use in insomnia and sleep disorders. It offers Ebb Insomnia Therapy, a drug-free insomnia therapy.

Eric Nofzinger founded Cereve in 2008 that later became Ebb Therapeutics. aIts headquarters in Pittsburgh in Pennsylvania.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$38M
Ebb Therapeutics has raised a total of $38M in funding over 2 rounds. Their latest funding was raised on Jan 5, 2017 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 5, 2017 Series B $38M 2 Kohlberg Kravis Roberts Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Ebb Therapeutics is funded by 2 investors. Kohlberg Kravis Roberts and Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Kohlberg Kravis Roberts Yes Series B
Versant Ventures Series B